Newer oral blood thinners were linked to lower nonmajor bleeding risk than warfarin in adults with sickle cell disease, a ...
Agios Pharmaceuticals is seeking accelerated approval from the U.S. FDA for its oral medication mitapivat for treating sickle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results